1. Presentation “multi-company survey on the use and characterization of polysorbates in biotech products”;Wuchner,2020
2. A review of formulations of commercially available antibodies;Strickley;J Pharm Sci,2021
3. FDA inactive ingredients database; PS20. https://fda.report/UNII/7T1F30V5YH, PS80 https://fda.report/UNII/6OZP39ZG8H (both accessed December 8, 2021)
4. Pediatric safety of polysorbates in drug formulations;Kriegel;Children (Basel),2019
5. Parenteral protein formulations: an overview of approved products within the European Union;Gervasi;Eur J Pharm Biopharm,2018